Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms.
Flow cytometry
Immunophenotyping
MDS
Myelodysplastic syndromes/neoplasms
Myeloid maturation
Journal
Clinics in laboratory medicine
ISSN: 1557-9832
Titre abrégé: Clin Lab Med
Pays: United States
ID NLM: 8100174
Informations de publication
Date de publication:
12 2023
12 2023
Historique:
medline:
31
10
2023
pubmed:
22
10
2023
entrez:
21
10
2023
Statut:
ppublish
Résumé
Myelodysplastic syndromes/neoplasms (MDS) are a heterogeneous class of hematopoietic stem cell neoplasms characterized by ineffective hematopoiesis leading to peripheral cytopenias. This group of diseases is typically diagnosed using a combination of clinical, morphologic, and genetic criteria. Many studies have described the value of multiparametric flow cytometry (MFC) in the diagnosis, classification, and prognostication of MDS. This review summarizes the approach to MDS diagnosis and immunophenotypic characterization using MFC and describes the current state while highlighting future opportunities and potential pitfalls.
Identifiants
pubmed: 37865501
pii: S0272-2712(23)00070-7
doi: 10.1016/j.cll.2023.06.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
521-547Informations de copyright
Crown Copyright © 2023. Published by Elsevier Inc. All rights reserved.